경막외 마취 및 액와신경 차단시 Lidocaine 의 혈중농도

Forty adult patients who received lumbar epidural anesthesia and axillary nerve block were assigned to four groups. Of these, 15 patients in group 1 (lumbar epidural anesthesia group) were given 1.5% lidocaine 400 mg (27 ml) and 15 patients in group 2 (lumbar epidural anesthesia group) were given li...

Full description

Saved in:
Bibliographic Details
Published inKorean journal of anesthesiology Vol. 22; no. 6; pp. 910 - 914
Main Authors 임정혁, Jung Hyuk Yim, 이원형, Won Hyung Lee, 이정은, Jung Eun Lee, 김혜자, Hae Ja Kim, 최세진, Se Jin Choi
Format Journal Article
LanguageKorean
Published 대한마취통증의학회(구 대한마취과학회) 30.12.1989
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Forty adult patients who received lumbar epidural anesthesia and axillary nerve block were assigned to four groups. Of these, 15 patients in group 1 (lumbar epidural anesthesia group) were given 1.5% lidocaine 400 mg (27 ml) and 15 patients in group 2 (lumbar epidural anesthesia group) were given lidocaine with epinephrine (200,000:1) in the same volume and concentration as in group l. 5 patients in group 3 (axillary nerve block group) were given lidocaine in the same volume and concentration and 5 patients in group 4 (axillary nerve block group) were given lidocaine with epinephrine (200,000:1). The plasma concentration of lidocaine were measured by immunofluorescence assay and the peak concentration were achieved 15 and 30 min, after injection in group 1, 2, respectively. Similar results were observed in group 3 and 4. The peak plasma concentration in group 1, 2,3 and 4 were 2.85±1.17, 1.81±0.60, 2.35±0.97 and 1.62± 0.67 μg/ml (Mean±SD), respectively. and the time course of plasma levels of lidocaine in group 2 and 4 lower than those in group 1 and 2. These results indicate the mixed injection of 1.5% lidocaine 400 mg with epinephrine is considered safe when there is no contraindication because plasma concentration is reduced significantly.
Bibliography:The Korean Society of Anesthesiologists
ISSN:2005-6419
2005-7563